2011 B.Sc. Hons (Pharmacology), University of Queensland
Wei Huang Goh (Jason) research areas focus on improving pharmacological outcomes by enhancing drug formulation and/or engineering approaches and to develop robust and relevant invitro and invivo models to evaluate therapeutics. He received a BSc degree, double major in Genetics and Pharmacology (2010) and a first class honours degree in Pharmacology from the University of Queensland (2011) where he studied and characterized novel therapeutics in a rodent model of Painful Diabetic Neuropathy. After graduation, he spent two years at the Centre for Integrated Preclinical Drug Development at UQ looking at Pharmacodynamics of novel analgesics in rodent models of Pain and analytical evaluation of pain therapeutics. Thereafter he spent another two years developing rodent models of cancer to evaluate novel anticancer therapeutics and the analytical evaluation and optimization of these therapeutics at the Drug Development Unit based at Institute of Molecular and Cellular Biology, A*star. Jason is currently a PhD student at SUTD and is working at the interface of bioengineering and pharmacology to advance drug delivery technology at Hashimoto’s Laboratory.